Medicap Bone and Joint Health effervescent powder
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Vitamine D Source : Cholécalciférol | 500 UI |
| Calcium Source : Citrate de calcium | 500 mg |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Exosquelette de crabe | 1,500 mg |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 90,000 FCC PU |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 1,500 mg |
| Vitamine K2 Source : Vitamin K2 | 100 mcg |
| Magnésium Source : Malate de magnésium | 150 mg |
Non-medicinal ingredients
Acide citrique, D-Fructose, Saveur de framboise, Saveur d'orange, Extrait de fruit de monk, Dioxyde de silicium, Saveur d'ananas, Saveur de vanille, Bicarbonate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Portion(s) | 1 Tous les jours |
Uses authorised in Canada
As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps in energy metabolism, tissue formation and bone development. Helps to build strong bones and teeth. Helps to relieve (joint) pain associated with osteoarthritis (of the knee). Used in herbal medicine to help relieve minor pain, swelling and inflammation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience constipation, diarrhoea, and/or vomiting. Stop use if hypersensitivity occurs. Some people may experience mild gastrointestinal bloating, constipation or indigestion. Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Stop use if diarrhea, abdominal pain, heartburn, nausea or vomiting occur. Stop use if hypersensitivity/allergy, nausea, vomiting or diarrhoea occurs.
- Contre-indications
Do not use this product with other potassium-containing supplements or with potassium-containing salt-substitutes.
Product record
- Other names
- Bone and Joint Health effervescent powder, Orgen Bone and Joint Health effervescent powder
- Licence holder
- Biowell Laboratories
- NPN or DIN-HM
- 80102033
- Status
- Active licence
- Licence date
- 22 June 2020
- Revision date
- Not provided
- Form
- Poudre
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80102033
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Medicap Bone and Joint Health effervescent powder (Biowell Laboratories): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80102033-medicap-bone-and-joint-health-effervescent-powder, updated 22 June 2020.